Patent · US Active

Drug delivery

US8224455B2 · kind B2 · utility

27Cited by
103References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 12, 2010
Grant dateJul 17, 2012
Priority date
Expiry dateOct 12, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T428/2984
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method and apparatus of treating tissue adjacent a bodily conduit using thermotherapy, while preventing obstructions of the bodily conduit due to edema, includes injection of a drug-encapsulated within a heat-sensitive carrier, such as a liposome, within a region of tissue to be treated. The heat produced by the energy-emitting source heats a portion of the tissue surrounding the bodily conduit to a temperature of approximately 43° C. for a time sufficient to destroy the heated portion of the tissue. In addition, the heat produced by the energy-emitting source activates the heat-sensitive carrier to activate the release of the encapsulated drug and the drug targets the tissue to be heated. The focused energy of the energy-emitting source together with the compression acting on the target area can assist in delivering drugs to the target area so that a natural stent has a long term efficacy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.